Zhengye Biotechnology Holding Ltd
For the period ended Jun 30, 2025. Filed Dec 12, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2025 · Filed Dec 12, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Segment reporting
Segment reporting
ASC 280,Segment Reporting, (“ASC 280”), establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers.
Based on the criteria established by ASC 280, our chief operating decision maker (“CODM”) has been identified as our Chief Executive Officer, who reviews unaudited condensed consolidated results when making decisions about allocating resources and assessing performance of the company. As a whole and hence, we have onlyone reportable segment. We do not distinguish between markets or segments for the purpose of internal reporting. As our long-lived assets are substantially located in the PRC, no geographical segments are presented. For the operating results of segment provided to and reviewed by CODM, please refer to the unaudited condensed consolidated statements of operations and comprehensive income (loss).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.